Doug Hampton

USD 125.78 million growth in the US Sex Reassignment Surgery Market between 2022-2027, Some of the key vendors include Boston Children’s Hospital, Boston Medical Center, and Cedars Sinai Health System- Technavio

by

NEW YORK, Feb. 18, 2024 /PRNewswire/ — The sex reassignment surgery market in US is to grow  by USD 125.78 million from 2022 to 2027 progressing at a CAGR of 10.84% during the forecast period. Key companies include- Boston Childrens Hospital, Boston Medical Center, Cedars Sinai Health System, CNY Cosmetic  and Reconstructive Surgery, Cornell University, Denver Health, Harvard University, Icahn School of Medicine at Mount Sinai, Mass General … Read more

YS Biopharma Announces Results of Extraordinary General Meeting and Responds to False Statements about the Meeting

by

GAITHERSBURG, Md., Feb. 16, 2024 /PRNewswire/ — YS Biopharma Co., Ltd. (Nasdaq: YS) (“YS Biopharma” or the “Company”), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced the results of its extraordinary general meeting (the “EGM”) held on February … Read more

China Medical University Hospital (CMUH) in Taiwan Upgrades Smart Healthcare with Gen AI

by

Establishing a comprehensive “AI-assisted Physician” using generative AI from Google Cloud, including MedLM TAICHUNG, Feb. 17, 2024 /PRNewswire/ — China Medical University Hospital (CMUH) in Taiwan announced its collaboration with Google Cloud in mid-December 2023. Using Google Cloud’s generative AI technology, including MedLM, which is a large language model built on Med-PaLM 2, CMUH has developed a comprehensive “AI-assisted Physician” … Read more

National Veterans Non-Profit Operation Song Appoints Jon Foti as CEO

by

With Expansion, the Organization Begins Search for New Office Space in Nashville TN NASHVILLE Tenn., Feb. 16, 2024 /PRNewswire/ — Operation Song®, the 501(c)(3) non-profit that pairs veterans and active-duty military with professional songwriters to tell their stories through song, announces the appointment of Jon Foti as Chief Executive Officer (CEO). Foti assumes the role after … Read more

WellBiz Brands Inc. Names Franchise Industry Veteran Amanda Clark as CEO

by

Experienced Executive to Drive Next Phase of Growth for Leading Franchise Platform of Best-in-Class Beauty and Wellness Brands DENVER, Feb. 15, 2024 /PRNewswire/ — WellBiz Brands Inc. (“WellBiz Brands”), the pre-eminent beauty and wellness franchise platform, today announced that Amanda Clark, a seasoned franchise industry executive, has been appointed Chief Executive Officer, effective March 12, 2024. … Read more

Global Hearing Aids Market Insights 2024-2029

by

DUBLIN, Feb. 14, 2024 /PRNewswire/ — The “Global Hearing Aids Market – Focused Insights 2024-2029” report has been added to  ResearchAndMarkets.com’s offering. The global hearing aids market is forecast to reach $8.55 billion by 2029 from US$6.66 Billion in 2023, growing at a CAGR of 4.25%, . The market growth can be attributed to the growing … Read more

Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion Proteins

by

OSAKA, Japan, Feb. 14, 2024 /PRNewswire/ — Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; “Ono”) today announced that it has entered into a drug discovery collaboration and option agreement with Shattuck Labs, Inc. (Austin, Texas, USA; CEO: Taylor Schreiber; “Shattuck”) to generate bifunctional fusion proteins for pathways involved in autoimmune and inflammatory … Read more

New England Biolabs® Launches NEBNext® Enzymatic 5hmC-seq Kit, for enzyme-based 5hmC detection at single-base resolution

by

New bisulfite-free system allows scientists to accurately and sensitively discriminate 5hmC from un-modified cytosine and 5mC from a wide range of DNA inputs, advancing epigenetics research. IPSWICH, Mass., Feb. 13, 2024 /PRNewswire/ — New England Biolabs (NEB®) today announced the launch of the NEBNext Enzymatic 5hmC-seq Kit (E5hmC-seq™), a novel enzyme-based method for the specific … Read more

Meridian Bioscience Senior Director of R&D, Dr. Dan (Dror) Siman-Tov, to Spotlight Lateral Flow Innovations at the Advanced Lateral Flow Conference 2024

by

CINCINNATI, Feb. 12, 2024 /PRNewswire/ — Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, is proud to announce that Dr. Dan (Dror) Siman-Tov, Ph.D., MBA, Senior Director of R&D, Diagnostics, will be presenting at the Advanced Lateral Flow Conference 2024. The event is scheduled to take place at … Read more

NRXP) Announces Advance of $5 Million Milestone Payment from Partners Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd. (1975.TW)

by

Companies continue to work collaboratively to advance NRX-101 through registrational trials NRx remains eligible for an additional $324 million in development and sales milestones, as well as tiered double-digit royalties upon approval and commercialization of NRX-101. Payment materially extends the Company’s cash runway RADNOR, Pa., Feb. 11, 2024 /PRNewswire/ — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx … Read more